This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated SATB2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SATB2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~82.6 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Ubl conjugation | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A02588 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | mouse brain tissue lysate (catalog A02588) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A02588 · (A) 2 and (B) 4 μg/mL (catalog A02588) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
SATB2 is predicted at 82.6 kDa; isoforms and phosphorylation could affect migration, but no empirical band size or visible effect is established.
| Band near 82.6 kDa | Consistent with the predicted SATB2 mass; identity requires controls |
| Several bands at different positions | Isoforms 1 and 2 are possible contributors, but their migration is unknown |
| Doublet near the expected position | Possible isoform or phosphorylation effects; neither is demonstrated here |
| Little or no band in soluble lysate | Nuclear matrix SATB2 may be poorly extracted |
| Predicted mass of 82.6 kDa | Provides a sequence-based reference for band position |
| Isoform 1 | Its individual apparent size is not supplied |
| Isoform 2 | Its size relative to isoform 1 is not supplied |
| Alternative splicing | Could yield different band positions, but distinct migration is unconfirmed |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Nuclear matrix SATB2 may resist extraction | Check a nuclear matrix fraction and a positive control |
| Band higher than expected | The supplied features do not establish the cause of slower migration | Compare with a positive control and test band identity by SATB2 depletion |
| Band lower than expected | An isoform is possible, but its mass is unknown | Check band identity by SATB2 depletion |
| Multiple bands | Isoforms 1 and 2 are possible contributors | Use SATB2 depletion to identify specific bands |
| Weak or no signal | Nuclear matrix SATB2 may be underrepresented in the extract | Assess nuclear matrix extraction and run a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | endocrine cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | neuronal cells | High | Protein (IHC) | HPA → |
| Colon | endocrine cells | High | Protein (IHC) | HPA → |
| Rectum | endocrine cells | High | Protein (IHC) | HPA → |
| Small intestine | endocrine cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for SATB2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
All four listed anti-SATB2 antibodies have Western blot images: A02588 in mouse brain, and M02588, A02588-2, and M02588-2 in human cell lysates. Reported bands are approximately 83 or 90 kDa. These images document the named samples only.
Which to pick: For mouse brain, consider A02588. For human lysates, M02588 reports an 83-kDa band in three cell lines, M02588-2 reports 90 kDa in four, and A02588-2 reports 90 kDa in HEL. A02588 and M02588 list rat reactivity, without rat blot examples.